Supplementary figures for Cladribine (2-CdA) improves cutaneous manifestations, DLQI and MC-QoL of patients with mastocytosis

Published: 9 January 2024| Version 1 | DOI: 10.17632/tk68xz7nmh.1
Contributors:
Hélène Bugaut, Hervé Maillard, Caroline Jacobzone Leveque, Naeda Haddad, Francois Le Pelletier, Frédéric Charlotte, Michel Arock, Patrice Dubreuil, Cristina Bulai Livideanu, olivier Hermine, Stéphane Barete

Description

This set of supplementary figures illustrates additional content of the article "Cladribine (2-CdA) improves cutaneous manifestations, DLQI and MC-QoL of patients with mastocytosis"

Files

Institutions

  • Assistance Publique - Hopitaux de Paris
  • Sorbonne Universite
  • Hopitaux Universitaires Pitie Salpetriere-Charles Foix

Categories

Dermatology, Cladribine, Systemic Mastocytosis, Mastocytosis

Licence